Citation: P. Berghammer et al., Nuclear medicine and breast cancer: a review of current strategies and novel therapies, BREAST, 10(3), 2001, pp. 184-197
Authors:
Obwegeser, R
Berghammer, P
Lorenz, K
Auerbach, L
Kubista, E
Citation: R. Obwegeser et al., Color Doppler sonography of the lateral thoracic (breast-feeding) arteries: a new approach to the diagnosis of breast disease?, ULTRASOUN O, 18(5), 2001, pp. 515-519
Authors:
Obwegeser, R
Berghammer, P
Muellauer-Ertl, S
Kubista, E
Sinzinger, H
Citation: R. Obwegeser et al., 99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions, BREAST CANC, 62(3), 2000, pp. 253-258
Authors:
Rodrigues, M
Chehne, F
Kalinowska, W
Berghammer, P
Zielinski, C
Sinzinger, H
Citation: M. Rodrigues et al., Uptake of Tc-99m-MIBI and Tc-99m-tetrofosmin into malignant versus nonmalignant breast cell lines, J NUCL MED, 41(9), 2000, pp. 1495-1499
Authors:
Obwegeser, R
Berghammer, P
Rodrigues, M
Kubista, E
Sinzinger, H
Citation: R. Obwegeser et al., Use of Tc-99m-furifosmin scintigraphy - Planar and SPECT - to evaluate suggestive palpable and nonpalpable breast lesions, J NUCL MED, 41(3), 2000, pp. 426-428
Authors:
Obwegeser, R
Berghammer, P
Rodrigues, M
Granegger, S
Hohlagschwandtner, M
Kucera, H
Singer, C
Berger, A
Kubista, E
Sinzinger, H
Citation: R. Obwegeser et al., A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions, EUR J NUCL, 26(12), 1999, pp. 1553-1559
Authors:
Egarter, C
Sator, M
Berghammer, P
Huber, J
Citation: C. Egarter et al., Efficacy, tolerability, and rare side effects of tibolone treatment in postmenopausal women, INT J GYN O, 64(3), 1999, pp. 281-286
Authors:
Leitich, H
Egarter, C
Kaider, A
Hohlagschwandtner, M
Berghammer, P
Husslein, P
Citation: H. Leitich et al., Cervicovaginal fetal fibronectin as a marker for preterm delivery: A meta-analysis, AM J OBST G, 180(5), 1999, pp. 1169-1176